Histologic assessment of tumor-associated CD45+ cell numbers is an independent predictor of prognosis in small cell lung cancer

Chest

Volumn 143, Issue 1, 2013, Pages 146-151

  Wang, Wei ^a,c   Hodkinson, Philip ^b,c   McLaren, Fiona ^c   Mackean, Melanie J ^e   Williams, Linda ^d   Howie, Sarah E M ^c   Wallace, William A H ^c,f   Sethi, Tariq ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CROSSHOUSE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Edinburgh Cancer Centre   (United Kingdom)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CELL ACTIVITY; CELL COUNT; CELL INFILTRATION; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; LYMPHOID CELL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIMARY TUMOR; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL PREDICTION; TUMOR ASSOCIATED LYMPHOID CELL; TUMOR BIOPSY;

EID: 84871966745     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0681     Document Type: Article

References (27)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581-592. (Pubitemid 46359643)
2. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol. 1999;10(suppl 5):S3-S6. (Pubitemid 29522774)
3. Ettinger DS. Overview and state of the art in the management of lung cancer. Oncology (Williston Park). 2004;18(7)(suppl 4):3-9.
4. El Maalouf G, Rodier JM, Faivre S, Raymond E. Could we expect to improve survival in small cell lung cancer? Lung Cancer. 2007;57(suppl 2):S30-S34. (Pubitemid 47188080)
5. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24(28):4539-4544. (Pubitemid 46630948)
6. Bremnes RM, Sundstrom S, Aasebø U, Kaasa S, Hatlevoll R, Aamdal S; Norweigian Lung Cancer Study Group. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer. 2003;39(3):303-313. (Pubitemid 36279450)
7. Ellyard JI, Simson L, Parish CR. Th2-mediated anti-tumour immunity: friend or foe? Tissue Antigens. 2007;70(1):1-11. (Pubitemid 46890289)
8. Graus F, Keime-Guibert F, Reñe R, et al. Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain. 2001;124(Pt 6):1138-1148. (Pubitemid 32510382)
9. Manley GT, Smitt PS, Dalmau J, Posner JB. Hu antigens: reactivity with Hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol. 1995;38(1):102-110.
10. Graus F, Dalmou J, Reñé R, et al. Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol. 1997;15(8):2866-2872. (Pubitemid 27330014)
11. Masuno T, Ikeda T, Yokota S, Komuta K, Ogura T, Kishimoto S. Immunoregulatory T-lymphocyte functions in patients with small cell lung cancer. Cancer Res. 1986;46(8):4195-4199. (Pubitemid 16075930)
12. Fischer JR, Schindel M, Stein N, et al. Selective suppression of cytokine secretion in patients with small-cell lung cancer. Ann Oncol. 1995;6(9):921-926.
13. Fischer JR, Schindel M, Bülzebruck H, Lahm H, Krammer PH, Drings P. Decrease of interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer. Ann Oncol. 1997;8(5):457-461. (Pubitemid 27310690)
14. Johnston-Early A, Cohen MH, Fossieck BE Jr, et al. Delayed hypersensitivity skin testing as a prognostic indicator in patients with small cell lung cancer. Cancer. 1983;52(8):1395-1400.
15. Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. J Clin Oncol. 2007;25(7):869-875. (Pubitemid 350002888)
16. Iwamoto M, Shinohara H, Miyamoto A, et al. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer. 2003;104(1):92-97. (Pubitemid 36184151)
17. +/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 2005;102(51):18538-18543.
18. Yu P, Fu YX. Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest. 2006;86(3):231-245. (Pubitemid 43276955)
19. Bröcker EB, Kolde G, Steinhausen D, Peters A, Macher E. The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas. J Cancer Res Clin Oncol. 1984;107(1):48-52. (Pubitemid 14192355)
20. Mostofi FK, Sesterhenn I. Plenary lecture: lymphocytic infiltration in relationship to urologic tumors. Natl Cancer Inst Monogr. 1978;49(49):133-141.
21. Murphy J, O'Sullivan GC, Lee G, et al. The inflammatory response within Dukes' B colorectal cancers: implications for progression of micrometastases and patient survival. Am J Gastroenterol. 2000;95(12):3607-3614.
22. Ugolini C, Basolo F, Proietti A, et al. Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma. Thyroid. 2007;17(5):389-393. (Pubitemid 46878841)
23. Johnson SK, Kerr KM, Chapman AD, et al. Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer. 2000;27(1):27-35.
24. Bremnes RM, Al-Shibli K, Donnem T, et al. The role of tumor-infiltrating immune cells and chronic inflammation at the tumor site on cancer development, progression, and prognosis: emphasis on non-small cell lung cancer. J Thorac Oncol. 2011;6(4):824-833.
25. Ignatius Ou SH, Zell JA. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM edition. J Thorac Oncol. 2009;4(3):300-310.
26. Herth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax. 2006;61(9):795-798. (Pubitemid 44369405)
27. Wallace WAH, Monaghan HM, Salter DM, Gibbons MA, Skwarski KM. Endobronchial ultrasound-guided fine-needle aspiration and liquid-based thin-layer cytology. J Clin Pathol. 2007;60(4):388-391. (Pubitemid 46596557)